136 related articles for article (PubMed ID: 28916138)
1. Peptide YY induces characteristic meal patterns of aged mice.
Mogami S; Yamada C; Fujitsuka N; Hattori T
Horm Behav; 2017 Nov; 96():62-68. PubMed ID: 28916138
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
3. Gut hormone PYY(3-36) physiologically inhibits food intake.
Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR
Nature; 2002 Aug; 418(6898):650-4. PubMed ID: 12167864
[TBL] [Abstract][Full Text] [Related]
4. PYY(3-36) into the arcuate nucleus inhibits food deprivation-induced increases in food hoarding and intake.
Teubner BJ; Bartness TJ
Peptides; 2013 Sep; 47():20-8. PubMed ID: 23816798
[TBL] [Abstract][Full Text] [Related]
5. The gut hormone peptide YY regulates appetite.
Batterham RL; Bloom SR
Ann N Y Acad Sci; 2003 Jun; 994():162-8. PubMed ID: 12851312
[TBL] [Abstract][Full Text] [Related]
6. Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.
Wang L; Gourcerol G; Yuan PQ; Wu SV; Million M; Larauche M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G45-56. PubMed ID: 19892938
[TBL] [Abstract][Full Text] [Related]
7. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
8. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
9. Peptide YY signaling in the lateral parabrachial nucleus increases food intake through the Y1 receptor.
Alhadeff AL; Golub D; Hayes MR; Grill HJ
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E759-66. PubMed ID: 26330345
[TBL] [Abstract][Full Text] [Related]
10. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
Ortiz AA; Milardo LF; DeCarr LB; Buckholz TM; Mays MR; Claus TH; Livingston JN; Mahle CD; Lumb KJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):692-700. PubMed ID: 17671099
[TBL] [Abstract][Full Text] [Related]
11. Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM
Br J Pharmacol; 2003 Jun; 139(4):863-71. PubMed ID: 12813010
[TBL] [Abstract][Full Text] [Related]
12. Peptide YY Causes Apathy-Like Behavior via the Dopamine D2 Receptor in Repeated Water-Immersed Mice.
Yamada C; Mogami S; Kanno H; Hattori T
Mol Neurobiol; 2018 Sep; 55(9):7555-7566. PubMed ID: 29429048
[TBL] [Abstract][Full Text] [Related]
13. Peptide YY (3-36) modulates intracellular calcium through activation of the phosphatidylinositol pathway in hippocampal neurons.
Domingues MF; de Assis DR; Piovesan AR; Belo CAD; da Costa JC
Neuropeptides; 2018 Feb; 67():1-8. PubMed ID: 29157865
[TBL] [Abstract][Full Text] [Related]
14. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
[TBL] [Abstract][Full Text] [Related]
15. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
16. Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY.
Flannery BM; Clark ES; Pestka JJ
Toxicol Sci; 2012 Dec; 130(2):289-97. PubMed ID: 22903826
[TBL] [Abstract][Full Text] [Related]
17. Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.
Nishizawa N; Niida A; Adachi Y; Masuda Y; Kumano S; Yokoyama K; Asakawa T; Hirabayashi H; Amano N; Takekawa S; Ohtaki T; Asami T
Bioorg Med Chem Lett; 2017 Aug; 27(16):3829-3832. PubMed ID: 28684122
[TBL] [Abstract][Full Text] [Related]
18. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour.
Scott V; Kimura N; Stark JA; Luckman SM
J Neuroendocrinol; 2005 Jul; 17(7):452-7. PubMed ID: 15946163
[TBL] [Abstract][Full Text] [Related]
19. Involvement of apolipoprotein A-IV and cholecystokinin1 receptors in exogenous peptide YY3 36-induced stimulation of intestinal feedback.
Whited KL; Tso P; Raybould HE
Endocrinology; 2007 Oct; 148(10):4695-703. PubMed ID: 17641001
[TBL] [Abstract][Full Text] [Related]
20. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
Riediger T; Bothe C; Becskei C; Lutz TA
Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
